W
WAVEMAN · COMPANY
ICU · Seastar Medical Holding Corp
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

ICU

SeaStar Medical Holding Corp
MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0001831868
C-SUITE BUYING · 1☆ WATCH
INSIDER NET · 180D
$2.5K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
11
13F, latest reported quarter
REVENUE GROWTH
+814.1%
XBRL, annual
NET MARGIN
-984.6%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$2.5K over 180 days
+$2.5K over 90 days
more than 70% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
11 funds added or opened last quarter
below 84% of Medical Devices
REVENUE
+814.1% year over year
more than 99% of Medical Devices
MARGIN
-984.6% net margin
below 97% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
2.1% of shares outstanding short · 1.5 days to cover · settled 2026-07-31
below 61% of Medical Devices
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -67.5%
-67.5%12M
-76%-39%-2%+35%2025-092025-102025-122026-032026-052026-072026-09 2025-12-09 · Messinger Michael bought $5.1K2026-08-18 · Messinger Michael bought $2.5K2025-12-19 · Baird Jennifer A bought $1.0K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders are net buyers of their own stock.
The record shows a net $2.5K bought by insiders over 180 days, 11 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, SeaStar Medical Holding Corp insiders bought a net $2.5K of stock across 26 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Messinger Michael
Chief Financial Officer
BUY
2026-08-18
750.0
$2.5K
Baird Jennifer A
Director
BUY
2025-12-19
4,200.0
$1.0K
Messinger Michael
Chief Financial Officer
BUY
2025-12-09
14,500.0
$5.1K
Van Heel Kenneth
Director
BUY
2025-08-27
10,000.0
$8.6K
Van Heel Kenneth
Director
BUY
2025-08-26
25,000.0
$22.2K
26 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 21 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BOOTHBAY FUND MANAGEMENT, LLC
245,200.0 sh
$899.9K
GEODE CAPITAL MANAGEMENT, LLC
49,593.0 sh
$182.0K
VANGUARD CAPITAL MANAGEMENT LLC
33,091.0 sh
$121.4K
UBS Group AG
32,199.0 sh
$115.2K
VANGUARD FIDUCIARY TRUST CO
13,692.0 sh
$50.2K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Fidelity Extended Market Index Fund
$61.4K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$88.8K POSITION · AS OF 2026-03-31
0.0%
Fidelity Series Total Market Index Fund
$11.0K POSITION · AS OF 2026-02-28
0.0%
Fidelity Nasdaq Composite Index Fund
$1.2K POSITION · AS OF 2026-02-28
0.0%
Fidelity Total Market Index Fund
$6.1K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$1.2M$135.0K$0
GROSS PROFIT$1.2M$135.0K$0
OPERATING INCOME$-12.2M$-17.8M$-14.2M$-11.6M
NET INCOME$-12.2M$-24.8M$-26.2M$-12.2M
EPS (DILUTED)-6.63-30.26-1.48
OPERATING CASH FLOW$-13.6M$-16.0M$-10.3M$-7.8M
LONG-TERM DEBT$4.1M$7.7M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →